Synchronous B-lymphoblastic leukemia/lymphoma and subcutaneous panniculitis-like T-cell lymphoma in an 11-year-old pediatric patient
4 affiliations
- 1Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400 Thailand
- 2Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400 Thailand
- 3Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, 10400 Thailand
- 4Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, 10540 Thailand
Abstract
Background: Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is rare in pediatric patients, whereas B-lymphoblastic leukemia/lymphoma (B-ALL) is a common childhood hematologic malignancy. The synchronous occurrence of these two distinct lymphoid neoplasms is exceedingly rare, with only two previously reported pediatric cases.
Case presentation: We describe the case of an 11-year-old boy with biopsy-proven SPTCL whose staging marrow examination revealed concurrent B-ALL. The patient was treated according to the B-ALL protocol, and the cutaneous lesions resolved promptly after induction therapy.
Conclusion: This case highlights the importance of comprehensive skin biopsy and staging. Management in such cases should be directed toward the B-ALL component.
Related
- 179 Machine learning-based prediction of CAR-T cell therapy response in pediatric acute lymphoblastic leukemia patients using single-cell multi-omics features
- Real-world efficacy and safety of blinatumomab across three clinical settings in pediatric B-cell acute lymphoblastic leukemia: a single-center retrospective cohort study
- Resistance mechanisms and translational bottlenecks in CAR-T cell therapy for pediatric acute lymphoblastic leukemia: a perspective
- Impact of Obesity on Chemotherapy Pharmacokinetics, Toxicity, and Survival Outcomes in Pediatric Acute Lymphoblastic Leukemia.
- Minor Myeloid Leukemic Populations in Pediatric Acute Lymphoblastic Leukemia: A Potentially Underrecognized Mixed-Phenotype Tumor?
BibTeX
@article{limchantra2026synchronous,
title = {{Synchronous B-lymphoblastic leukemia/lymphoma and subcutaneous panniculitis-like T-cell lymphoma in an 11-year-old pediatric patient}},
author = {Phuphinyo Limchantra and Jirat Temsangsukmanee and Suradej Hongeng and Kran Suknuntha},
journal = {BMC Pediatrics},
year = {2026},
month = aug,
doi = {10.1186/s12887-026-07270-y},
url = {https://doi.org/10.1186/s12887-026-07270-y},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Synchronous B-lymphoblastic leukemia/lymphoma and subcutaneous panniculitis-like T-cell lymphoma in an 11-year-old pediatric patient
AU - Phuphinyo Limchantra
AU - Jirat Temsangsukmanee
AU - Suradej Hongeng
AU - Kran Suknuntha
PY - 2026
DA - 2026/08/06
JO - BMC Pediatrics
DO - 10.1186/s12887-026-07270-y
UR - https://doi.org/10.1186/s12887-026-07270-y
AB - Background: Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is rare in pediatric patients, whereas B-lymphoblastic leukemia/lymphoma (B-ALL) is a common childhood hematologic malignancy. The synchronous occurrence of these two distinct lymphoid neoplasms is exceedingly rare, with only two previously reported pediatric cases. Case presentation: We describe the case of an 11-year-old boy with biopsy-proven SPTCL whose staging marrow examination revealed concurrent B-ALL. The patient was treated according to the B-ALL protocol, and the cutaneous lesions resolved promptly after induction therapy. Conclusion: This case highlights the importance of comprehensive skin biopsy and staging. Management in such cases should be directed toward the B-ALL component.
SN - 1471-2431
ER -